Jermasek Douglas
SEC insider (Form 3/4/5 filer). CIK 0001955273. EVP, Corporate Strategy at Unicycive Therapeutics, Inc. (UNCY). 3 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in MOUNTAIN VIEW, CA.
Companies Jermasek Douglas has filed insider reports for
- Unicycive Therapeutics, Inc. (UNCY): Officer, EVP, Corporate Strategy
Jermasek Douglas
CIK: 0001955273
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
UNCY
Unicycive Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- May 14, 2026UNCY
Unicycive Therapeutics, Inc.
AwardDirectRestricted Stock Units
169.5K shares- - May 14, 2026UNCY
Unicycive Therapeutics, Inc.
AwardDirectRestricted Stock Units
169.5K shares- - Jul 28, 2025UNCY
Unicycive Therapeutics, Inc.
AwardDirectStock Options
10K shares-
1-3 of 3 transactions